Dr Aamer Khan appointed by ABG Lab as global KOL

Aesthetic doctor, regenerative medicine expert, and Harley Street Skin Clinic clinical director and co-founder Dr Aamer Khan (MB ChB) has been appointed as ABG Lab’s Global key opinion leader (KOL). 

Dr Kahn joins ABG Lab’s growing team of Global KOLs alongside Dr Michael Kane, and Professor Yana Yutskovskaya at a period of global growth for the brand. 

“We’re delighted to announce our partnership with Dr Khan and are thrilled that he will be offering ABG Lab’s cutting-edge skincare technologies and intradermal injections at his Harley Street Skin Clinic,” says president and chief executive of ABG Lab, Dr Elina Tester. “Our vision to bring the very best in regenerative medicine to patients across the globe aligns perfectly with that of Dr Khan, and this partnership signifies our ongoing commitment to collaborating with the very best in the industry and those who share our values and passion for offering patients the epitome of technology and technique.” 

Dr Khan adds: “Regenerative Medicine in aesthetic treatments is the next big growth area in our industry and has been at the heart of our practice since 2006. Having practised and studied this subject extensively, I am very excited and honoured to be partnering with such a progressive and forward-thinking brand like ABG Lab which has launched an innovative and ground-breaking concept in the injectable arena. Their hybrid products are a result of years of ground-breaking research and development, which have culminated in injectables that specifically target and activate cellular regeneration of the skin. 

“Meso-Wharton P199 is a mesotherapy treatment that targets the skin's endogenous stem cells, stimulating their proliferation and differentiation, thereby providing the fundamental basis for skin renewal. Meso- Xanthin F199 is an innovative therapy that targets the genes that are responsible for the proteins involved in skin regeneration, these have specific functions of inhibiting chronic inflammatory mediators and restoring damaged DNA, thereby improving the quality of life of the skin cells, making them more durable. 

“These products are safe, well tolerated and produce outstanding results for patients, and I’m looking forward to stepping into the future of our industry together.”